Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Massimiliano Mazza

Massimiliano Mazza

PhD

IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST)

Strategies being explored to enhance the efficacy of CAR T-cells in hematological malignancies

Strategies being explored to enhance the efficacy of CAR T-cells in hematological malignancies

Massimiliano Mazza • 20 Mar 2025

The challenges associated with developing CAR-T products for T-cell malignancies

The challenges associated with developing CAR-T products for T-cell malignancies

Massimiliano Mazza • 5 Mar 2025

The development of a novel TRBC1-directed CAR T-cell therapy for T-cell malignancies

The development of a novel TRBC1-directed CAR T-cell therapy for T-cell malignancies

Massimiliano Mazza • 3 Mar 2025

Exciting research in the CAR-T space: the promise of allogeneic therapies

Exciting research in the CAR-T space: the promise of allogeneic therapies

Massimiliano Mazza • 1 Dec 2022

Insights into the ‘Alleanza Contro il Cancro’ and its CAR-T project

Insights into the ‘Alleanza Contro il Cancro’ and its CAR-T project

Massimiliano Mazza • 1 Dec 2022